The overall lifetime risk of heart failure (HF) is similar between men and women, however,
there are marked sex differences in the landscape of this condition that are both important …

Heart failure with preserved ejection fraction (HFpEF), a major public health problem that is
rising in prevalence, is associated with high morbidity and mortality and is considered to be …

Obesity and heart failure with preserved ejection fraction (HFpEF) represent two
intermingling epidemics driving perhaps the greatest unmet health problem in …

Background: Heart failure (HF) with preserved ejection fraction (HFpEF) is a heterogeneous
syndrome. Phenotyping patients into pathophysiologically homogeneous groups may …

Background: Unlike heart failure with reduced ejection fraction, there is no approved
treatment for heart failure with preserved ejection fraction, the predominant phenotype in …

Background: Demographic differences in expected NT-proBNP (N-terminal pro-B-type
natriuretic peptide) concentration are not well established. We aimed to establish reference …

Aims Women are more likely to develop heart failure with preserved ejection fraction
(HFpEF) than men. We studied the relationship between sex and cardiovascular structure …

Measurement of biomarkers has revolutionized the work-up of patients with suspected
cardiovascular disease. The most widely used contemporary cardiovascular biomarkers are …

The prevalence of left ventricular diastolic dysfunction (LVDD) sharply increases in women
after menopause and may lead to heart failure. While evidence suggests that estrogens …

Heart failure (HF) is a complex condition affecting> 40 million people worldwide. It is defined
by failure of the heart to pump (HF with reduced ejection fraction) or by the failure of the …